Job offersmore »
- Plant Specialist - Melbourne, Australia
- General Manager European Region - Bologna, Italy
- Einkaufsverantwortlicher / Kundenbetreuer - Die Schweiz
- Continuous Improvement Specialist - Berkel en Rodenrijs, Nederland
- Innovation Leader - Johnston (Iowa), USA
- VP of Sales - Montreal, Canada
- IPM Consultant - Adelaide Plains, Australia
- National Nursery Manager - Australia
- Substrate Grower - Launceston CBD, Tasmania
- Product manager for growing media - Finland or Estonia
Top 5 - yesterday
Top 5 - last week
Top 5 - last month
- US (AZ): The future of farming takes root
- Retractable roof helps AU greenhouse function with extremely low energy costs
- US: Regulatory barriers to developing innovative agricultural biotechnology
- Ultra-thin MA film seeks to revolutionize packaging
- Over 9 million views for this hydroponic lettuce video
Exchange ratesmore »
Bayer, Monsanto start $2.5 billion asset saleBayer and Monsanto are launching asset sales worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger, people close to the matter said.
To kick off an auction process, Bayer's advisors will send out information packages next week to prospective bidders for the businesses, which have been divided into three bundles of assets, the people said.
Bayer and Monsanto have said in the past that they expect to divest activities with combined sales of up to $1.6 billion.
While it could not be learned what businesses will be put on the auction block, antitrust and industry experts expect Bayer to potentially divest soybean, cotton and canola seed assets as well as LibertyLink-branded crops that are resistant to its glufosinate herbicide, an important alternative to Monsanto's Roundup Ready seeds.
Overall, regulatory hurdles to the deal are seen as manageable because Bayer's main business in agriculture is pesticides while Monsanto's focus is on genetically modified seeds.
Read more at Reuters
Publication date: 3/15/2017
Other news in this sector: